IO Biotech Files 8-K on Security Holder Vote Matters
Ticker: IOBT · Form: 8-K · Filed: Jun 9, 2025 · CIK: 1865494
| Field | Detail |
|---|---|
| Company | Io Biotech, Inc. (IOBT) |
| Form Type | 8-K |
| Filed Date | Jun 9, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: corporate-governance, voting
TL;DR
IO Biotech held a security holder vote on June 5th. Details to follow.
AI Summary
IO Biotech, Inc. filed an 8-K on June 9, 2025, reporting on matters submitted to a vote of its security holders as of June 5, 2025. The filing details the company's corporate structure, including its incorporation in Delaware and its principal executive offices located in Copenhagen, Denmark.
Why It Matters
This filing indicates that IO Biotech held a vote of its security holders, which could pertain to significant corporate decisions or changes that may impact the company's future direction.
Risk Assessment
Risk Level: low — This is a routine filing reporting on a vote of security holders, not indicating any immediate financial distress or significant operational change.
Key Players & Entities
- IO Biotech, Inc. (company) — Registrant
- June 5, 2025 (date) — Earliest event reported
- June 9, 2025 (date) — Date of report
- Delaware (jurisdiction) — State of incorporation
- Copenhagen, Denmark (location) — Address of Principal Executive Offices
FAQ
What specific matters were submitted to a vote of IO Biotech's security holders?
The filing does not specify the exact matters voted upon, only that "Submission of Matters to a Vote of Security Holders" is the item information reported.
When was the earliest event reported in this 8-K filing?
The earliest event reported was on June 5, 2025.
What is the principal executive office address for IO Biotech, Inc.?
The principal executive offices are located at Ole Maaløes Vej 3, DK-2200 Copenhagen N, Denmark.
In which U.S. state is IO Biotech, Inc. incorporated?
IO Biotech, Inc. is incorporated in Delaware.
What is the filing date of this 8-K report?
This 8-K report was filed on June 9, 2025.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on June 9, 2025 regarding IO Biotech, Inc. (IOBT).